In CLL, removal of sialic acid by neuraminidase treatment leads to desialylation of CD49d and inhibition of VCAM-1- and fibronectin-dependent migration, adding a new layer of regulation to an already complex spectrum of VLA-4 modulations [142]. Here, VCAM1 is linked to B-cell chronic lymphocytic leukemia.